Member Info for Tyke68

Showjumper

Well done on TRUE even though if we get a great trial update it may have another quick rise, but it will probably be short lived unless we announce a sale of the data and designations then we may get the special dividend we hope for.

Does anyone know if the 0.51 buys are actually sells? Unless we get a big sell before the close the sp movement seems a bit weird. If it follows the normal pattern of this week it will probably jump up at close to be blue with a few percentage rise.

Thanks

Showjumper

Have you ever considered the major shareholders have taken a major hit with the drop in the sp? We all hoped for a major windfall from the GaM trial, indeed we may still. I imagine the decision to not currently do phase 2 was not taken lightly. However, after hearing more of the facts I now agree with the decision.

My money, my choices. Similar to your choice to come on this board and berate us all and call us rats.

Thanks

Showjumper

Seriously why do you post on this board? You never add anything, always criticise and then go on TRUE and say it is your share of the year.

I say have a good weekend because I was brought up to be polite to others.

We all know what last weekend was like, thank you. I did notice you never said how many shares you own in this company. If you don’t like the company and people being well mannered that is your choice but I will keep saying have a good weekend because I actually mean that to people on here including you.

Again, I hope you have a good weekend everybody.

Thanks

I hope everybody has a good weekend.

Thanks

If you look at the trades since Friday mid morning there has been far more buys compared to sells but the sp is still doing it’s normal up or down 10 percent.

I suspect those who have had enough have already sold up by now. Is the company only worth just over £1m? Absolutely not. Look at how it was valued before we got engrossed by the GAM trial. Several people have always said the imaging side was the money generator. I didn’t believe them and hoped it was the trial (it may still be). I was wrong.

I think we will just keep getting small fluctuations in the sp and people quietly building a position whilst we await the shareholder update, trial results, annual report and anything else we don’t know about.

For those posters who have left, goodbye and thank you.

For those new to the board or are still hanging in there let’s see what we hear in the next 3 months or so. And good luck.

United we stand

Thanks

T

Just for future reference to finish this topic off, if shareholders continued to hold the same amount (not included Shrek) then we have over 13m shares which is over the 5% .

Thanks to everybody who helped out with this.

I will stop dominating the board and just wait and watch.

Many thanks

T

Shrek

Good luck in the future

T

Apologies I wrote truetide but should have been Kirkstall

Sorry i ran out of characters.

I personally think we should wait for the update and annual reports. But everybody has to make their own decisions. I may buy some more shares when funds become available and it is still this cheap.

I hope all this has been helpful, apologies if you don’t agree.

That’s me done for a while.

Thanks

T

As I stated earlier I have just had a conversation with Mr Brown. He had contacted me asking if we could talk.

So the bit that people want to hear

The company has being trying to engage with partners for a phase 2 partner. One of the technical issues has been the trial was being extended and one patient is still enrolled. I think that is great news for the patient.

We do own the data but MCW will publish the results. These results haven’t been completed yet, patient still alive.

Possible partners obviously want the phase 1 results which have not been fully written up yet and Mr Brown couldn’t give a definitive date for when they would be. It is MCW not IB that is publishing the data.

The cost of the trial was hoped to be $2.5m with a start date of approximately in a year’s time and taking about 3 years to complete. Which the company did also look at self funding.

The company has been talking to an institution/hospital about partnering with the trial. However, the other people never actually committed and a decision kept being delayed.

What I hadn’t realised is how the clinical trial process is quite competitive with oncologist’s deciding who to refer their patient for a trial. As GBM is quite a niche disease (thankfully) and there being other trials available it is quite competitive.

So last week at a board meeting and the non decision from the prospective partner a decision was taken to concentrate on the core business as this has been suffering due to the GBM trial. (We have commented previously how MS is trying to do too much)

So my understanding is due to the lack of commitment from a prospective partner, the results still not being published, the competitiveness of clinical trials, oncologists choice, time the trial would take to complete we have stopped it to concentrate on the core IB business. (As stated in the RNS this could change I assume, let’s see how much interest the results generate I would guess)

We do own the data.

After hearing this I personally agree with that decision.

Truetide - discussed briefly and TB believes this is a wise future investment for the company.

The board are hoping to share a comprehensive strategy update soon, hopefully February.

Mr Brown has subsequently messaged (after the meeting) to say the EAP is ongoing for now.

Did I believe Mr Brown, the simple answer is yes I do.

Do I now think the right decision was made re the trial, yes I do.

Do I now wish we had been given more information in the last update, yes but they were rushing after the board meeting to update us with regards their decision.

Will I keep investing in IBAI, yes

Have I bought the Porsche yet, no

I would like to take this opportunity to thank Mr Brown for giving me the chance to talk to him. I hope I have given an accurate account of our conversation. Apologies if I have got any details wrong.

I hope members of this board find this new information helpful. Personall

Dear all

I have just had a phone call with Mr Brown. I will send the details in a bit

Thanks

T

So as we have passed the deadline (odds are we get a RNS later this week that has been delayed to spite us) shareholders need to decide if we are united as a group.

Our mantra used to be In IB we trust, should it now be United we stand?

Will people please considering emailing the board etc?

I am not sure about how many people have said how many shares they own via email to BB but we have over the 3% to be classed as a group as a significant shareholder. Do we have enough to be over 5% to call for a general, I don’t know?

For both personal reasons, that some on the board are aware of, and me believing we need somebody with a far better understanding of how businesses work and the regulations I will stop posting incessantly and hope others take up the mantle to hold the board accountable whilst I take more of a back seat.

I have tried to collate all the questions I could think of and the contacts for all the people I could think of. Will these people respond, my honest feeling is I don’t know but if anything does happen in the future the more people we can say who asked questions the better. Yrek said he complained to the FCA previously so tha will be logged. The company secretary Apex should have but they haven’t replied to me yet.

That’s why we need somebody far better acquainted with these rules and regulations to take this further. I invested in IBAI so shows how much I know! There are people on here who have shown that knowledge. Can they please help?

Many thanks to everybody. We need to keep trying.

“United we stand”

Thanks

T

Do we know if the last few trades were actually buys not sells?

Thanks

Showjumper if you read the latest RNS you will understand everybody’s sentiment towards the flow of news from the BoD

Thanks

A reminder of the email addresses I am aware of including AM who was a director during the Kirkstall issue.

Mr Brown you have stated that this board is monitored for “seriously mis-leading assertions” so would that include Semantics offering of potential value of phase 1/2 drug companies and even mentioning Kirkstall at the weekend?

These are the contact details I know of

Trevor Brown email

trevorebrown@hotmail.com

Michael Schmainda email

mike@imagingbiometrics.com

Brett Skelly

brettskelly@gbac.co.uk

Gbac contact

info@gbac.co.uk

Our company secretary

Apex Group

https://www.apexgroup.com/contact-page/

Financial conduct authority

https://www.fca.org.uk/contact

Alliance news

newsroom@alliancenews.com

musella@virtualtrials.org

Thank you

Morning deadline day

GAM trial

Why the sudden change from November?

What about all the phase 2 protocols that MCW staff have been working on for over 2 years?

When will the data be published?

Who owns the data?

Did the FDA meeting occur?

Did we reapply for breakthrough drug designation?

What happened with all the talks with prospective partners?

What happened with the talk with other cancer centres?

What is happening with the EAP and its real world data?

Has our data and funds been used to set up the Gabriel trial?

Are there talks about a sale or licence agreement happening?

Kirkstall

Who initiated this purchase? Was it True or IBAI? Can we

See the records relating to this initial contact?

IB imaging etc

What amount of revenue has this generated and is expected in the near future?

Are there discussions/plans to sell IB Nimble or Neuro etc?

Board

Do we have a chairman as mentioned in the annual report for talking to major shareholders?

Who represents private shareholders?

Will the board recognise a group of individuals as significant shareholders?

Is semantic an insider?

Plus anything else I have forgotten

So Mr Brown you have stated “ We take seriously our responsibilities to ensure shareholders are kept up to date via the regular publication of RNS reports and the Interim and Annual reports, this policy ensues that all shareholders are treated equally as far as information is concerned”

We as shareholders would actually like to be kept up to date and currently feel this is not happening.

Thank you

T

Thanks Mallettp

Do you know what the main differences are if any?

Thanks

Kane

I would say the qsmetric link is more valid with the current company structure compared to Kirkstall. qSMetric seems a good deal.

I hope that way anyway

Thanks

Dear all

Mr Brown has just confirmed to me Brett is not the company chairman. Brett is the independent non-executive director not the Chairman.

I would like to go on record in apologising to Brett for this misunderstanding and if my emails to him believing he was the chairman were written in the wrong manner.

Thanks

T

As I thought yesterday I got this from Google (not sure if AI generated, I am guessing it is)

Yes, a group of shareholders can absolutely request a general meeting, typically requiring at least 5% of voting rights (or sometimes fewer members if they hold significant capital) under the UK's Companies Act 2006; they can requisition the directors to call one, and if directors fail to act, the shareholders themselves can call the meeting and recover reasonable expenses from the company.

How it Works (UK Companies Act 2006):

Threshold: Shareholders holding at least 5% of the company's paid-up share capital with voting rights can require directors to call a general meeting (Section 303).

The Requisition:

It must be in writing and deposited at the company's registered office.

It must state the "objects" (purpose) of the meeting, meaning the resolutions they want to propose (e.g., removing directors, specific actions).

Director's Duty: Directors must call the meeting within 21 days of receiving the requisition, and the meeting must be held within 28 days of the notice being sent out.

Shareholder Action (If Directors Fail): If directors don't comply, the shareholders who made the request (or those representing over half the voting rights of all requisitionists) can call the meeting themselves.

Expenses: The company must reimburse the shareholders for their reasonable expenses in holding the meeting, and these costs can be deducted from directors' pay if they were in default, notes CMS LAW-NOW.

So the company registrars are Apex in Jersey, and have the same address as our registered office I believe. Confusingly our website says it is the address of Imaging Biometrics not IBAI.

Do we hold more than 5%? So far I know of 8m shares we need 12.5m. Not sure how many people have emailed in their amounts.

For the record I have been told Brett is out of the office until Thursday

Thanks